DilutionScan

Trading small caps? Know the dilution. DilutionScan reads the SEC filings so you don't have to: • Every warrant, convertible, ATM and shelf, linked to the filing it came from • Dilution ratings: overall risk, offering ability, overhead supply, history and cash need • A dilution screener across every company we cover • A live filings feed showing what changed in each filing • Cash position and runway from the latest 10-Q/10-K • Float and shares outstanding, measured from SEC filings • Upcoming reverse splits Available on web, iOS and Android. Links below 👇

🔒 PRIVATE PLACEMENT $NXB · NextBoat Consumer · Nano cap ($37.5M) Facility: $5.0M revolving credit, $2.0M funded Oct 22 Rate: 12.99% fixed, matures Oct 22, 2027 Warrants: 100.0K at $2.50, 5yr (lender consideration) Collateral: 7.87mln CEO-affiliated shares pledged (~31.3% of 25.1M outstanding) 8-K Items 1.01/2.03/3.02: subsidiary Off The Hook Yacht Sales NC entered a $5.0M revolving facility with RLLT Capital; CEO Ruegg entities have pledged 41.3% of outstanding shares across two lenders.

🔴 OFFERING PRICED $MGN · Megan Holdings Comms · Nano cap ($4.43M) Raise: up to $7.5M gross (169% of market cap) Shares: 15.0M at $0.50 (-84% vs prior close $3.06) Agent: Prime Number Capital, 6.0% fee Dilution: ~14x share count expansion vs 1.07M Class A pre-offering 424B4: best-efforts public offering of up to 15.0M Class A ordinary shares; no minimum raise, no escrow; proceeds for business ventures, acquisitions, and working capital.

✂️ SPLITS & UPLISTINGS TODAY · Thu Oct 29 ✂️ $ATYR 1-for-40 reverse split (aTyr Pharma) ✂️ $ENHA 1-for-10 reverse split (Enhanced Group)

🌅 OVERNIGHT DILUTION · Thu Oct 29 🔴 $INMB $4.5M gross (11% of market cap) + 3.0M warrants at $1.65 📄 $LXEO S-3 shelf filed 📄 $ARAI S-3 filed 📄 $ABTS F-1 filed 4 sub-$300M filings tracked by Signal8 since yesterday's close.

🔴 OFFERING PRICED $INMB · INmune Bio Healthcare · Nano cap ($42.5M) Raise: $4.5M gross (11% of market cap) Shares: 3.0M at $1.50 (-1% vs prior close $1.52) Warrants: 3.0M at $1.65, exp 2032 (100% coverage) Agent: A.G.P./Alliance Global Partners, 7.0% fee Dilution: 10.7% of 27.96M shares pre-offering 424B5: registered direct offering of 3.0M shares with 3.0M private placement warrants; proceeds for CORDStrom development and working capital.

⚡ SHELVES NOW EFFECTIVE · Wed Oct 28 ⚡ $DFNS $250.0M S-3 shelf effective Oct 22 ⚡ $ADIL $137.1M S-3 resale effective Oct 26 ⚡ $WORX $34.2M S-3 resale effective Oct 26 ⚡ $BURU $18.4M S-3 resale effective Oct 22 ⚡ $ACTU S-1 effective Oct 26 ⚡ $PULM S-3 effective Oct 22 ⚡ $MGN F-1 effective Oct 27 ⚡ $IPW S-3 effective Oct 27 +3 more sub-$300M registrations declared effective in the last 7 days, tracked by Signal8. These companies can now sell off these registrations.

📊 TODAY'S DILUTION · Wed Oct 28 🟠 $XXII $18.8M ATM (936% of market cap) 🔴 $ACTU $11.0M gross (114% of market cap) 🟠 $OSS $50.0M ATM (32% of market cap) 📝 $WFF 23.1M shares resale (zero-price warrants) 📄 $SLXN S-3 filed 📄 $SCNI F-3 filed 📄 $QNRX S-3 filed 7 sub-$300M filings tracked by Signal8 today.

📝 RESALE REGISTERED $AMZE · Amaze Holdings Technology · Nano cap ($401K) Resale: 50.0M shares (ELOC draws, C/M Capital Master Fund) Dilution: 138% of 36.1M shares outstanding (Oct 15, 2026) ELOC: up to $100.0M, 36-month term, purchases at 95% of VWAP/lowest price Commitment fee: $2.0M in Series F preferred (converts up to 80.0M shares at $0.025) Reverse splits: 1-for-23 (Jun 2025), 1-for-8 (Jul 2026); delisted NYSE American Oct 12, 2026 424B3 registers 50.0M shares for resale by C/M Capital Master Fund under a $100M equity line dated Oct 15, 2026; company receives proceeds only on draws; OTC Pink price $0.0112.

📝 RESALE REGISTERED $NKLR · Terra Innovatum Global Industrials · Micro cap ($264M) Resale: 94.8M shares (86% of 110.5M outstanding, Aug 13, 2026) Warrants: 5.5M shares upon exercise Converts: 40.2M shares upon mandatory preferred conversion Price at filing: $2.12 (Oct 27, 2026) 424B3 Prospectus Supplement No. 8 to S-1 updates the resale registration with two Oct 2026 8-Ks disclosing KPMG dismissed Oct 12 and MaloneBailey re-engaged for FY2026; unremediated material weaknesses in internal controls disclosed for FY2025 and Q2 2026.

📝 RESALE REGISTERED $SLXN · Silexion Therapeutics Healthcare · Nano cap ($2.22M) Resale: 8.8M shares (61% of 14.5M outstanding, Sep 30, 2026) Warrants: 6.4M (Series F + G) at $0.2603 - above market ($0.1532) Potential proceeds: ~$1.75M (warrant cash exercises only; company receives none from resales) Reverse splits: 4th pending (1-for-24, Nov 2026); prior: 1-for-10, 1-for-15, 1-for-9 S-3 registers resale of 8.81mln shares covering Sept 2026 warrant inducement, Moringa Sponsor note conversions (1.41mln shares, subject to active litigation), and 740.2K shares issued to LifeSci Advisors; going concern disclosed; Nasdaq equity and bid-price deficiency notices outstanding.

📝 RESALE REGISTERED $SCNI · Scinai Immunotherapeutics Healthcare · Nano cap ($723K) Resale: 7.6M ADSs (288% of 2.63M ADSs outstanding) Warrants: Series A-1 at $1.20, Pre-Funded at $0.0001, Agent at $1.32 Potential proceeds: ~$6.16M (warrant cash exercises only; company receives none from resales) ADS price: $0.531 (Oct 27, 2026) - Series A-1 exercise price above market F-3 registers resale of 7.59mln ADSs issuable on warrant exercise by Armistice Capital and A.G.P./Alliance Global Partners from the Oct 13, 2026 private placement and warrant inducement; going concern disclosed.

Web: dilutionscan.com iOS: apps.apple.com/app/id6824367… Android: play.google.com/store/apps/d…

📝 RESALE REGISTERED $WFF · WF Holding Industrials · Nano cap ($7.96M) Additional shares: 23.1M (zero-price exercise, 15.8% of 145.9M outstanding Oct 27, 2026) Amended warrants: 2.57mln at $1.50 exercise price Multiplier: 18.0x (doubled from 9.0x original terms) Full exercise: 46.22mln shares total issuable Proceeds: none 424B5 Supplement No. 2 registers 23.1M additional shares from a warrant amendment that doubled the zero-price exercise multiplier to 18.0x; Additional Allocation of 12mln units was terminated Oct 21, 2026; warrants auto-exercise on termination date.

🟠 NEW ATM PROGRAM $OSS · One Stop Systems Technology · Micro cap ($169M) Capacity: up to $50.0M (30% of market cap) Agent: Piper Sandler, 3.0% commission Floor: $0.50/share (agent will not accept notices below this price) 8-K Item 1.01: OSS entered an Equity Distribution Agreement with Piper Sandler on Oct 28, 2026, off its S-3 shelf effective Sept 2, 2026; program runs three years from shelf effectiveness.

🟠 NEW ATM PROGRAM $OSS · One Stop Systems Technology · Micro cap ($169M) Capacity: up to $50.0M (30% of market cap) Dilution: up to ~33% of 25.0M shares outstanding Agent: Piper Sandler, up to 3.0% commission 424B5: OSS entered an at-the-market equity program to sell common stock from time to time at prevailing market prices; proceeds earmarked for growth strategies, potential acquisitions, and working capital.

🔴 OFFERING PRICED $ACTU · Actuate Therapeutics Healthcare · Nano cap ($9.65M) Raise: $11.0M gross (114% of market cap) Shares: 31.0M at $0.355 (-33% vs prior close $0.5279) Warrants: 15.5M at $0.45, unit pricing ($0.71 per 2 shares + 1 warrant) Over-allotment: 4.6M shares + 2.3M warrants (45-day option) Dilution: 129% of 24.0M shares pre-offering 424B5: public offering expected to close Oct 30; post-offering shares outstanding 55.0M; Nasdaq MVLS non-compliance deadline Jan 11, 2027; going concern disclosed.

🌅 OVERNIGHT DILUTION · Wed Oct 28 🟠 $XXII $18.8M ATM (936% of market cap) - agent added 📄 $QNRX S-3 shelf filed 2 sub-$300M filings tracked by Signal8 since yesterday's close.